Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.8165
-0.0043-0.52%
Volume:1.07M
Turnover:882.17K
Market Cap:68.40M
PE:-0.28
High:0.8520
Open:0.8125
Low:0.7700
Close:0.8208
Loading ...

Sutro Biopharma Inc : Wedbush Cuts to Neutral From Outperform; Cuts Target Price to $2 From $8

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Cut to Underperform From Buy by B of A Securities

Dow Jones
·
14 Mar

Truist Removes $15 Price Target From Sutro Biopharma, Keeps Buy Rating

MT Newswires Live
·
14 Mar

Sutro Biopharma downgraded to Underperform from Buy at BofA

TIPRANKS
·
14 Mar

Sutro Biopharma Names New CEO; Plans to Reduce Workforce by Nearly 50% After Portfolio Review

MT Newswires Live
·
14 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sutro Biopharma (STRO) and Generation Bio (GBIO)

TIPRANKS
·
14 Mar

Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
14 Mar

Sutro Biopharma Review Results in 50% Workforce Reduction, CEO Transition

Dow Jones
·
14 Mar

Sutro Biopharma FY 2024 GAAP EPS $(2.96) Misses $(2.92) Estimate, Sales $62.043M Beat $59.004M Estimate

Benzinga
·
14 Mar

BRIEF-Sutro Biopharma FY Revenue USD 62.043 Million

Reuters
·
14 Mar

Sutro Biopharma Inc - Cash Payments Associated With Restructuring Are Estimated to Be $40 to $45 Mln

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Inc - Jane Chung, President and COO, to Succeed BILL Newell as CEO and Board Director

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Inc - Will Reduce Its Organizational Headcount by Nearly 50 Percent

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Inc - Intends to Exit Its Internal Gmp Manufacturing Facility by Year-End

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of Its Next-Generation ADC Pipeline

THOMSON REUTERS
·
14 Mar

Sutro Biopharma Inc: Cash Runway Expected Into at Least Q4 2026

THOMSON REUTERS
·
14 Mar